Mohsin Tassawar Cheema

Mohsin Tassawar Cheema

Auto-generated profile, based on publicly available information

Mohsin Tassawar Cheema

Department of Cardiothoracic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, USA

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2025 in Current Microbiology
Verified
Journal Article
Closed access
PDF file
NANimra Arshad
Nimra Arshad
MCMohsin Tassawar Cheema
Mohsin Tassawar Cheema
AAAATIF AMIN
AATIF AMIN
RFRida Fatima
Rida Fatima
MSMounir M. Salem-Bekhit
Mounir M. Salem-Bekhit
Mohsin KhurshidMohsin Khurshid
Mohsin Khurshid

3 June 2026 in Canadian Journal of Microbiology
Verified
Journal Article
Closed access
AAAmna Aftab
Amna Aftab
AHAbid Hussain
Abid Hussain
SSSaba Saba
Saba Saba
AAAATIF AMIN
AATIF AMIN
MCMohsin Tassawar Cheema
Mohsin Tassawar Cheema
Mohsin KhurshidMohsin Khurshid
Mohsin Khurshid
Pseudomonas aeruginosa is a major opportunistic pathogen responsible for severe human infections and is increasingly associated with multidrug resistance and limited treatment options. In this study, we isolated and characterized bacteriophages targeting drug-resistant P. aeruginosa strains and evaluated their capacity to disrupt biofilms and modulate biofilm-associated gene expression. Phages recovered from sewage showed broad lytic activity against P. aeruginosa and were classified morphologically into the families Podoviridae and Myoviridae. Two phages, A2 and A4, exhibited the highest lytic activity against the resistant strains examined. Both phages significantly degraded preformed biofilms, with phage A4 showing comparatively stronger antibiofilm activity. In addition, phage exposure altered the expression of several biofilm-associated genes, including pelA, htpB, bifA, psl, fimW, and wspA. A notable finding was the reversal of bifA expression from downregulation at 12 h to upregulation at 24 h following treatment with phage A4. Collectively, these results demonstrate that phages A2 and A4 possess strong lytic and antibiofilm activities and are capable of modulating biofilm-associated transcriptional responses in drug-resistant P. aeruginosa. The findings support the potential application of bacteriophages as alternative therapeutic agents against drug-resistant biofilm-associated infections.

1 January 2026 in Canadian Journal of Infectious Diseases and Medical Microbiology
Verified
Journal Article
Open access
MSMuhammad Sarfraz
Muhammad Sarfraz
AAAATIF AMIN
AATIF AMIN
MNMuhammad Naveed
Muhammad Naveed
Mehboob AhmedMehboob Ahmed
Mehboob Ahmed
Shahida HasnainShahida Hasnain
Shahida Hasnain
AAAjaz Ahmad
Ajaz Ahmad
Objectives: This study investigated the prevalence of AmpC beta‐lactamase‐producing Escherichia coli and Klebsiella pneumoniae in clinical specimens collected in Lahore, Pakistan, and aimed to identify potential inhibitors targeting AmpC beta‐lactamases. Methods: A total of 17,500 clinical specimens were collected from June 2018 to June 2021 and analyzed for E. coli and K. pneumoniae . These isolates underwent phenotypic identification using microscopy and the API 20E kit. AmpC beta‐lactamase production was initially screened using cefoxitin disk diffusion and inhibitor‐based methods, while the presence of plasmid‐borne AmpC genes (CIT, EBC, and DHA) was confirmed by PCR. Additionally, the study used computational drug discovery techniques to screen for oxadiazole, quinazolinone, and sulfonylurea derivatives as potential inhibitors of the AmpC protein. Results: Our data showed high antibiotic resistance rates among E. coli and K. pneumoniae isolates: 74.5% were resistant to cefotaxime and ceftazidime, and 45% to cefoxitin. PCR testing revealed that the CIT gene was the most prevalent in both E. coli (65.4%) and K. pneumoniae (63%), while other genes (EBC and DHA) and combinations were also present ( p < 0.005). Using computational drug discovery, several compound libraries were screened against the AmpC protein. Tolbutamide showed the most promising results, with strong binding affinity and favorable drug‐like properties. Conclusion: Plasmid‐mediated AmpC beta‐lactamase‐producing E. coli and K. pneumoniae were highly prevalent, with the CIT genotype predominating among clinical isolates. Computational screening identified Tolbutamide as a promising lead compound, warranting further experimental validation before therapeutic application.

9 November 2026 in Scientific Reports
Verified
Journal Article
Open access
PDF file
RDRajeev Dhupar
Rajeev Dhupar
HUHannah M. Udoh
Hannah M. Udoh
NNNaila Noureen
Naila Noureen
CBCharles Edward Bardawil
Charles Edward Bardawil
XZXinyue Zhao
Xinyue Zhao
ASAdam Soloff
Adam Soloff
Since the 1950s, microplastics (MPs) have become omnipresent, representing a novel environmental hazard which continually deposits in our airways. Pulmonary macrophages (pMacs) orchestrate the balance between inflammation and tolerance required for homeostasis of the lung and are among the first immune cells to encounter inhaled MPs. Yet, how pMacs react to plastic deposition in the lung and implications for disease remain unknown. Here, we exposed mice in vivo, human precision-cut lung slices (hPCLS) ex vivo, and monocyte-derived macrophages and cell lines to polystyrene MPs in vitro. MP deposition in the lung and extrapulmonary tissues was determined over a 1-week period and pMacs from MP-laden lungs isolated for RNA-sequencing. We compared the effects of MPs or diesel exhaust particulate exposures on hPCLS viability and metabolism, monocyte-derived macrophage transcription, and macrophage mitochondrial function, inflammation, and antigen presentation. MPs readily translocated the lung and were observed in all organs examined within 1-day. pMacs from MP-exposed mice expressed transcriptional pathways associated with endocrine system disorders, tissue remodeling, and malignant disease. Macrophage phagocytosis was impaired through decreased mitochondrial function which could be rescued pharmacologically. MPs inhibited the ability of macrophages to effectively present OVA-antigen preventing TCR-specific activation, an effect that could be restored by blocking PD-1/PD-L1. These findings indicate that MPs impair macrophages via unique mechanisms linking phagocytic and bioenergetic dysfunction. Loss of antigen-presenting capabilities in MP-laden macrophages may compromise immunosurveillance. As such, MPs have the potential to increase susceptibility to lung disease independent of the conventional mechanisms of inflammation and oxidative stress.